Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohortCarmelo Gurnari, Maria Teresa Voso, Attilio Olivieri et al.|American Journal of Hematology|2023Cited by 43
Methodology and clinical utility of longitudinal <scp><i>UBA1</i></scp> tracking in <scp>VEXAS</scp> syndromeCarmelo Gurnari, Maria Teresa Voso, Monica Bocchia et al.|British Journal of Haematology|2024Cited by 10
<i>JAK2</i> is a critical therapeutic target in <scp>VEXAS</scp> syndrome treated with ruxolitinibAndrea Ceccardi, Gabriele Zoppoli, Lorenzo Ferrando et al.|British Journal of Haematology|2025Cited by 8